Schonfeld Strategic Advisors LLC - VISTAGEN THERAPEUTICS INC ownership

VISTAGEN THERAPEUTICS INC's ticker is VTGN and the CUSIP is 92840H202. A total of 75 filers reported holding VISTAGEN THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
Schonfeld Strategic Advisors LLC ownership history of VISTAGEN THERAPEUTICS INC
ValueSharesWeighting
Q2 2022$155,000
-28.6%
175,100
+0.1%
0.00%0.0%
Q1 2022$217,000
-71.2%
174,900
-54.7%
0.00%
-71.4%
Q4 2021$753,000
-35.0%
386,200
-8.6%
0.01%
-41.7%
Q3 2021$1,158,000
-40.1%
422,500
-31.1%
0.01%
-42.9%
Q2 2021$1,933,000
+236.8%
613,600
+127.4%
0.02%
+200.0%
Q1 2021$574,000
+277.6%
269,799
+245.5%
0.01%
+250.0%
Q4 2020$152,00078,1000.00%
Other shareholders
VISTAGEN THERAPEUTICS INC shareholders Q1 2021
NameSharesValueWeighting ↓
Henrickson Nauta Wealth Advisors, Inc. 200,000$24,9400.02%
GSA CAPITAL PARTNERS LLP 1,275,215$1590.02%
TKG Advisors, LLC 134,860$16,8170.01%
JOHNSON & JOHNSON 190,494$23,7550.01%
GPS Wealth Strategies Group, LLC 253,205$31,5750.01%
Performa Ltd (US), LLC 90,000$11,2230.01%
Garden State Investment Advisory Services LLC 30,000$3,7410.00%
Jackson Wealth Management, LLC 23,850$2,9740.00%
Twin Lakes Capital Management, LLC 12,500$1,5590.00%
Boyd Wealth Management, LLC 12,180$1,5190.00%
View complete list of VISTAGEN THERAPEUTICS INC shareholders